Medical

An article published in The Lancet on November 20, 2010 describes the case of a teen-aged boy who appeared to suffer from asthma exacerbations linked to emotional distress caused by his use of Facebook. His… Read more . . .

Researchers from the Medco Research Institute presented data at the 2010 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) showing that clinicians are prescribing ICS/LABA combination treatment for two thirds of… Read more . . .

A Phase 3 study of the Qnaze beclamethasone nasal spray from Teva has demonstrated that the product produced significant symptom relief compared to placebo, according to a Teva presentation at the 2010 Annual Meeting of… Read more . . .

An article in the November issue of the American Journal of Medicine reports that a study of almost 400,000 COPD and asthma patients showed a 34% increase in the rate of Type 2 diabetes among those using… Read more . . .

Almirall and Forest Laboratories have announced that a Phase 3 study of their aclidinium bromide DPI for the treatment of COPD produced significant improvement from baseline in FEV1 at clinical doses but underperformed when compared… Read more . . .

A group calling itself Safe and Healthy Use of Nasal sprays (SHUN) is trying to get out the message that "Addiction to over-the-counter medicated nasal spray is a serious problem in the United States" and… Read more . . .

Pharmaxis has announced that two Phase 3 trials of its Bronchitol inhaled mannitol in patients with cystic fibrosis demonstrated significant improvement in lung function with Bronchitol compared to the control group. The company also cites… Read more . . .

Data presented at the North American Cystic Fibrosis Conference by Transave shows "improved lung function with significant reduction in bacterial density" for CF patients treated with Arikace liposomal amikacin for inhalation. An affiliate of the… Read more . . .